This topic contains a solution. Click here to go to the answer

Author Question: A cognitive or cognitive-behaviorist who is more likely to use group counseling than other cognitive ... (Read 103 times)

mwit1967

  • Hero Member
  • *****
  • Posts: 501
A cognitive or cognitive-behaviorist who is more likely to use group counseling than other cognitive behaviorists is
 
  a. Meichenbaum
  b. Beck
  c. Bandura
  d. Ellis

Question 2

In which group is feedback to group members most emphasized?
 
  a. Developmental
  b. Client centered
  c. Cognitive
  d. Psychodynamic



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nmyers

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

d

Answer to Question 2

c




mwit1967

  • Member
  • Posts: 501
Reply 2 on: Jul 31, 2018
:D TYSM


jordangronback

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library